Healthcare AI companyCerviGuard live product

Clinician-led AI workflow software for cervical screening.

SmartClover builds healthcare AI where clinical work actually happens. CerviGuard helps cervical-screening teams structure intake, review cases with AI support, coordinate triage, and manage clinician-led follow-up.

CerviGuard sign-in page at cerviguard.link, the entry to the live workspace.
CerviGuard workspace proofThe live workspace entry at cerviguard.link, captured from the running product.

Product evidence and working routes

SmartClover links the live CerviGuard workflow to research context, trust material, and direct commercial paths for clinics, research partners, and investors.

CerviGuard add-case form for uploading a de-identified cervical image with clinical notes.

Research and service tracks around the flagship product

CerviGuard is the product teams review first. DataGems and the deployment services are the research and infrastructure conversations that follow.

Flagship product

CerviGuard

A live product for structured cervical screening workflows, AI-assisted review, and clinician-led follow-up.

Live research pilot

DataGems

A live research pilot for synthetic-data workflows, schema drafting, configured generation jobs, and reviewable exports.

Public research directions

Cancer prevention and decision support

SmartClover publicly discusses cancer prevention, secondary prophylaxis, early detection, and treatment-optimization research as active directions, not as released products.

Founder and research credibility

SmartClover's product work starts from cervical-screening research.

Founder Dr. Andreea Damian leads SmartClover from Cluj-Napoca with CerviGuard as the flagship product. The research links below are kept as context for the cervical-screening problem space; current product details come from CerviGuard, product, and trust pages.

PubMed 35197342 covers follow-up barriers after abnormal cervical screening results.PubMed 28460211 covers barriers to cervical screening participation in Romania.CerviGuard, GitHub, Hugging Face, and trust routes are available before outreach.

Public timeline: from screening research to a live product

These milestones connect the published screening research, the CerviGuard build, and how SmartClover works today.

2017 publication

Screening participation barriers documented

Social Science & Medicine published field research on Roma women and cervical screening participation in Romania.

2022 publication

Follow-up barriers researched in remote communities

BMJ Open published a protocol on facilitators and barriers to follow-up after abnormal cervical screening results in remote Romanian communities.

2024-2026 product build-out

CerviGuard moved into a live product surface

The public product surface, repository, and model hub provide a concrete flagship proof layer with supporting artifacts.

Current routes

Choose the right conversation

Contact, pricing, how-to-buy, proof, regulatory, and trust routes help each visitor decide where to start.

Clear next steps for buyers, partners, and investors

The site keeps one primary CTA while making audience-specific entry points clear for buyers, partners, and investors.

Book demo / Request pilot

For clinics, hospitals, and operators evaluating CerviGuard or a scoped product rollout.

Go to contact hub

Research partnership

For institutions exploring prevention, qualitative research, or model-development collaboration.

Go to contact hub

Investor inquiry

For investors and accelerators reviewing SmartClover's healthcare AI platform and public product evidence.

Go to contact hub

Everything a buyer, partner, or investor needs to vet SmartClover before reaching out.